Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 1404 of 6351
-
Nerve-Cutting surgery may boost diabetes remission after gastric bypass
Disease control Recruiting nowThis randomized, triple-blind clinical trial investigates whether adding truncal vagotomy to Roux-en-Y gastric bypass (RYGB) enhances remission of type 2 diabetes mellitus (T2DM) in patients with obesity. The study explores whether modulation of vagal signaling provides superior …
Sponsor: University Research Institute for the Study of Genetic & Malignant Disorders in Childhood • Aim: Disease control
Last updated Jun 27, 2026 12:26 UTC
-
Simple blood test could spot hidden liver disease in women
Diagnosis OngoingPrimary biliary cholangitis (PBC) is a chronic autoimmune disease characterized by progressive destruction of the small intrahepatic bile ducts, leading to cholestasis and potential progression to cirrhosis. Prognosis is favorable when diagnosed and treated early, while diagnosti…
Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS • Aim: Diagnosis
Last updated Jun 27, 2026 12:30 UTC
-
Can talk therapy plus yoga and meditation help veterans with PTSD function better?
Symptom relief Recruiting nowThe goal of this clinical trial is to determine whether which types of integrative care, meaning a combination of psychotherapy and mind-body interventions, lead to the most changes in functioning among Veterans with posttraumatic stress disorder (PTSD). The main aims are: 1. To…
Sponsor: Veterans Medical Research Foundation • Aim: Symptom relief
Last updated Jun 27, 2026 13:07 UTC
-
Can a liver drug help people with HIV? new trial aims to find out
Disease control Recruiting nowThe purpose of this research study is to test the safety and effectiveness of the study drug, resmetirom, in participants with MASLD and HIV. This is a research study to test a drug that is already on the market with a population that was not included in the original clinical tri…
Phase 2 • Sponsor: Naga P. Chalasani • Aim: Disease control
Last updated Aug 01, 2026 00:00 UTC
-
Hope for kids with rare bone disorder: new drug shows promise in Long-Term trial
Disease control By invitation onlyPhase 2, multicenter, OLE study to evaluate the long-term safety, tolerability, and efficacy of infigratinib, an FGFR (fibroblast growth factor receptor) 1-3-selective tyrosine kinase inhibitor, in participants with Hypochondroplasia (HCH) who previously completed ACCEL 2/3, and …
Phase 2 • Sponsor: QED Therapeutics, a BridgeBio company • Aim: Disease control
Last updated Aug 28, 2026 00:00 UTC
-
Could a diabetes drug shield Teens' kidneys?
Disease control Recruiting nowChronic kidney disease (CKD) is highly prevalent in the state of Aguascalientes, Mexico, particularly among adolescents and young adults. Epidemiologic and histologic studies suggest that this burden is largely driven by reduced nephron endowment of prenatal origin, leading to co…
Phase 4 • Sponsor: Centenario Hospital Miguel Hidalgo • Aim: Disease control
Last updated Jun 27, 2026 12:25 UTC
-
New combo therapy aims to help leukemia survivors shed pounds
Disease control Recruiting nowThis is a 28-week, single-arm, open-label phase II clinical trial evaluating the combination of Tirzepatide and remote, supervised, tailored resistance exercise training to achieve weight loss in adult survivors of childhood acute lymphoblastic leukemia (ALL) living with obesity …
Phase 2 • Sponsor: St. Jude Children's Research Hospital • Aim: Disease control
Last updated Jun 27, 2026 13:03 UTC
-
New drug combo targets tough cancers in Mid-Stage trial
Disease control Recruiting nowThis is a multicenter, open-label Phase II clinical study. The primary objective is to evaluate the investigator-assessed objective response rate of JS212 and JS213 as monotherapy and in combination regimens in patients with advanced solid tumors. This study aims to explore the s…
Phase 2 • Sponsor: Shanghai Junshi Bioscience Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
Can an older antibiotic combo fight sepsis and superbugs?
Disease control Recruiting nowNorwegian guidelines for empirical antibiotic therapy in suspected community acquired sepsis recommend the combination of narrow spectrum betalactam and aminoglycoside as the first choice, but broad spectrum betalactams are considered equally appropriate, effective, and safe. How…
Phase 4 • Sponsor: University Hospital, Akershus • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
New pill aims to unclog arteries in heart disease patients
Disease control Recruiting nowThis is a multicenter, randomized, double-blind, placebo parallel controlled study to evaluate the preliminary efficacy, safety, and PopPK profile of ABP-745 in patients with ASCVD. Efficacy of ABP-745 in reducing atherosclerotic plaque compared with placebo will be evaluated in …
Phase 2 • Sponsor: Atom Therapeutics Co., Ltd • Aim: Disease control
Last updated Jun 27, 2026 12:25 UTC
-
New weekly shot aims to tackle high blood pressure and obesity together
Disease control Recruiting nowA multicenter, randomized, double-blind, placebo-controlled clinical study to evaluate the efficacy and safety of IBI362 in participants with mild to moderate hypertension complicated by overweight/obesity who have not received antihypertensive drug treatment
Phase 3 • Sponsor: Innovent Biologics (Suzhou) Co. Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
Experimental Dual-Target CAR-T therapy takes aim at Hard-to-Treat plasma cell cancers
Disease control Recruiting nowThis is a single arm study to evaluate the safety and efficacy of CAR70-BCMA dual-target CAR-T cell therapy for relapsed and refractory plasma cell neoplasms.
Early phase 1 • Sponsor: The General Hospital of Western Theater Command • Aim: Disease control
Last updated Jun 27, 2026 13:05 UTC
-
New drug duo aims to shrink throat tumors before surgery
Disease control Not yet recruitingThis is a prospective, single-arm, Phase II clinical trial designed to evaluate the efficacy and safety of vibecotamab combined with putelimab in the treatment of locally advanced laryngeal carcinoma.
Phase 1/2 • Sponsor: Tang-Du Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:09 UTC
-
New taxane drug RP-001 enters human trials for Hard-to-Treat cancers
Disease control Not yet recruitingPhase 1/2a Study of RP-001 in participants with Advanced Malignancies
Phase 1/2 • Sponsor: Recurv Pharma Inc • Aim: Disease control
Last updated Jun 27, 2026 12:02 UTC
-
Can IVIG help premature Babies' lungs? new trial investigates
Disease control Recruiting nowIt is intended to examine the short-term and long-term efficacy and safety of intravenous immunoglobulin(IVIG) for the bronchopulmonary dysplasia in preterms born at 28 weeks and below. Participants will received continuous infusion IVIG 1 g/kg/day for the first 2 days, 0.5 g/kg/…
Phase 2 • Sponsor: International Peace Maternity and Child Health Hospital • Aim: Disease control
Last updated Jul 25, 2026 00:00 UTC
-
Could allergy and COPD drugs tame rheumatoid arthritis?
Disease control Recruiting nowRheumatoid arthritis is a chronic inflammatory disease that causes joint pain, swelling, and disability. Although standard disease-modifying antirheumatic drugs (DMARDs) are effective for many patients, some individuals continue to experience active disease and inflammation. The …
Phase 2 • Sponsor: Horus University • Aim: Disease control
Last updated Jun 27, 2026 12:32 UTC
-
New drug aims to ease tough schizophrenia symptoms
Symptom relief Recruiting nowEvaluate the efficacy, as well as safety and pharmacokinetics, of Roluperidone in improving the negative symptoms of schizophrenia in adult subjects in Phase A of study, followed by Phase B of study to evaluate the relapse rate of Roluperidone and antipsychotic medications.
Phase 3 • Sponsor: Minerva Neurosciences • Aim: Symptom relief
Last updated Jul 30, 2026 00:00 UTC
-
Spinal implant aims to restore leg movement in groundbreaking 2-person trial
Disease control By invitation onlyThis proof-of-concept case series will prospectively use magnetic resonance imaging (MRI) evidence of spared spinal cord neural fibers to guide the selection of 2 research participants to receive a surgically implanted epidural stimulator with the goal of restoring voluntary move…
Sponsor: University of Colorado, Denver • Aim: Disease control
Last updated Jun 27, 2026 13:04 UTC
-
Could an ADHD drug help curb cocaine addiction?
Disease control Recruiting nowIn The Netherlands, each year, about 15 thousand people come into treatment because of problems with cocaine use. There is no approved medication for treatment of cocaine addiction and the psychosocial treatment patients receive is not successful for everyone; many return to trea…
Phase 2 • Sponsor: Parnassia Addiction Research Centre • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
New narcolepsy pill aims to banish daytime drowsiness
Symptom relief Recruiting nowThe purpose of this study is to measure decreases in daytime sleepiness, and disease symptoms in participants with Narcolepsy Type 2 (NT2) when taking ALKS 2680 tablets compared with placebo tablets.
Phase 3 • Sponsor: Alkermes, Inc. • Aim: Symptom relief
Last updated Sep 05, 2026 00:00 UTC